Merck gets FDA approval for Welireg to treat VHL disease-related tumours
The company is working to optimise production of Welireg, which is an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Aug 21
The company is working to optimise production of Welireg, which is an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor,…
16 Aug 21
The immunogenicity of Ticovac was assessed in clinical studies across the population aged between 1 to 15 years…
13 Aug 21
A focus on clinical trial supply chains, how new technology is making trials easier and the pressure of…
13 Aug 21
Durezol is a topical corticosteroid, indicated for inflammation and pain associated with ocular surgery, and for endogenous anterior…
13 Aug 21
The majority of people vaccinated with Moderna’s vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants
12 Aug 21
The FDA approval is based on Phase 3 CLEAR/KEYNOTE-581 trial, in which Keytruda plus Lenvima combination was superior…
11 Aug 21
The MHRA approval allows the use of Epidyolex in England, Wales and Scotland, along with all 27 countries…
11 Aug 21
The new manufacturing facility will support Canada with direct access to domestically manufactured vaccines against respiratory viruses
10 Aug 21
Forxiga is an oral, once-daily sodium-glucose cotransporter 2 (SGLT2) inhibitor, with potential in preventing and delaying cardiorenal disease,…
10 Aug 21
The Phase 3 trial evaluated the efficacy, safety and pharmacokinetics of Polivy in combination with R-CHP, compared to…